The involvement of CCL2 in inflammatory and neurodegenerative diseases and functional dyspepsia [141–143] point to the involvement of the miR-325-5p/CCL2 signalling in chronic visceral pain in IBS patients and other patients with the gastrointestinal disorder as well. Here, CCL2 is linked to irritable bowel syndrome.